20 results
PRE 14A
CNTA
Centessa Pharmaceuticals plc
26 Apr 24
Preliminary proxy
4:36pm
. as an “audit committee financial expert,” as defined under the applicable rules of the SEC. The Audit Committee’s responsibilities include … (“SEC”), and the Board has determined that Carol Stuckley, M.B.A. is an “audit committee financial expert,” as the SEC has defined that term in Item 407
DEFA14A
CNTA
Centessa Pharmaceuticals plc
23 May 23
Additional proxy soliciting materials
4:08pm
research with the aim of bringing assets through candidate selection. Each is led by a subject matter expert based on their unique knowledge and expertise
DEF 14A
b0ati6q2iuf
23 May 22
Definitive proxy
8:00am
10-K
weljywd2z
30 Mar 22
Annual report
12:00am
424B4
m1h ekg6jsr
1 Jun 21
Prospectus supplement with pricing info
4:07pm
S-1/A
EX-3.1
e2g9ff9cklydt
12 May 21
IPO registration (amended)
5:19pm
S-1/A
EX-10.27
w1ce sypixdu
12 May 21
IPO registration (amended)
5:19pm
S-1/A
EX-10.28
fqh869fxreza8dlpjtg
12 May 21
IPO registration (amended)
5:19pm
S-1/A
dpy4ku1
12 May 21
IPO registration (amended)
5:19pm
S-1
EX-10.12
26rd6s3yyx
21 Apr 21
IPO registration
10:14am
S-1
2yy9z ziqrge
21 Apr 21
IPO registration
10:14am
S-1
EX-10.11
hl04aht20cdqo 7kq
21 Apr 21
IPO registration
10:14am
S-1
EX-10.10
4dwvp
21 Apr 21
IPO registration
10:14am
DRS
5v66n x06f9
15 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next